Epithelial to mesenchymal markers and clinical outcomes on erlotinib in stage IV non-small cell lung cancer patients.
Mark Pool
No relevant relationships to disclose
Mary J. Fidler
Consultant or Advisory Role - Genentech
Sanjib Basu
No relevant relationships to disclose
Brett Mahon
No relevant relationships to disclose
Lela Buckingham
No relevant relationships to disclose
Kelly Kaiser Walters
No relevant relationships to disclose
Marta Batus
No relevant relationships to disclose
Thomas A. Hensing
No relevant relationships to disclose
Jeffrey A Borgia
No relevant relationships to disclose
Philip D. Bonomi
Consultant or Advisory Role - Astellas Pharma; Genentech